VISICORT publishes in Frontiers in Immunology

The paper ‘Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?’ is based on the work of Dr Paul Lohan, Dr Oliver Treacy, Prof Matthew Griffin, Prof Thomas Ritter and Dr Aideen Ryan of the National University of Ireland Galway. The publication appears in the November 24, 2017, edition of Frontiers in Immunology. This research was funded by VISICORT, amongst other sources. Read the entire manuscript here.

Front. Immunol., 24 November 2017

VISICORT partners involved in exciting new stem cell project

VISICORT partners NUI Galway, Orbsen, and Pintail are involved in NEPHSTROM, a new European project, which was launched last week. NEPHSTROM involves eleven partners from Ireland, the UK, Germany, and the Netherlands, and has received €6 million funding under the European Union’s Horizon 2020 funding programme. NEPHSTROM will evaluate the clinical safety and efficacy of a next-generation cell therapy discovered by Galway-based Orbsen Therapeutics, to combat diabetic kidney disease. Find out more about the project at

VISICORT abstract accepted for oral presentation at ESBB’s 2014 Annual Conference, Leipzig

VISICORT have had an abstract accepted for oral presentation at ESBB’s 2014 Annual Conference. The ESBB conference will take place in Leipzig, Germany from Tuesday 21st to Friday 24th October.

Read more

Launch of VISICORT

Welcome to the VISICORT Project.  We are very excited to be launching the project in April 2014.

Please follow us on facebook or twitter for more updates.